Weight Regain After Stopping GLP-1 RA: The Biology of Rebound and Long-Term Management Strategies

After stopping semaglutide or tirzepatide, most patients regain significant weight within 1–2 years. Learn the biology behind rebound, what STEP 4 trial data shows, and strategies for long-term weight maintenance.

Drug Interactions with GLP-1 RA Medications: Oral Contraceptives, Thyroid Drugs, and Diabetes Medications

GLP-1 RA medications slow gastric emptying and can alter absorption of oral drugs. Learn about clinically significant interactions with contraceptives, thyroid medications, diabetes drugs, and more.

Long-Term Use of GLP-1 RA: Cardiovascular Benefits (SELECT Trial), Kidney Protection, and Chronic Disease Prevention

Beyond weight loss, GLP-1 RA medications offer proven long-term cardiovascular and kidney benefits. A review of the SELECT and FLOW trials and emerging evidence for chronic disease prevention.